Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Adenosine monophosphate-activated protein kinase (AMPK) is a highly conserved heterotrimeric enzyme complex that serves as the master regulator of cellular energy homeostasis [UniProt P54646]. It consists of a catalytic alpha subunit and regulatory beta and gamma subunits, which allow it to sense fluctuations in the cellular AMP:ATP and ADP:ATP ratios [Hardie et al., 2012, Nature Reviews Molecular Cell Biology]. When energy levels are low, AMPK is activated to restore balance by promoting catabolic pathways that generate ATP, such as glucose uptake and fatty acid oxidation, while simultaneously inhibiting energy-consuming anabolic processes like lipid and protein synthesis [PubMed: 22551880]. Due to its central role in metabolism, AMPK is a primary therapeutic target for type 2 diabetes and metabolic syndrome, with metformin being its most well-known indirect activator [PubChem: 4091]. Furthermore, AMPK's influence on cell growth, autophagy, and mitochondrial health has made it a subject of intense research in oncology and neurodegenerative diseases [PubMed: 27229108].
AMPK acts as a cellular energy sensor activated by increases in the AMP:ATP and ADP:ATP ratios. It is activated allosterically by AMP/ADP binding to the gamma subunit and by phosphorylation of the alpha subunit at Thr172 by upstream kinases such as LKB1 and CaMKK2 [Hardie et al., 2012, Nature Reviews Molecular Cell Biology]. Once active, AMPK phosphorylates downstream targets to switch off ATP-consuming anabolic pathways and switch on ATP-producing catabolic pathways.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Adenosine monophosphate-activated protein kinase (AMPK) (AMPK).